Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
$1K Sell
13
-139
-91% -$7.44K 0.05% 179
2016
Q4
$8K Sell
152
-113
-43% -$5.6K 0.04% 191
2016
Q3
$13K Sell
265
-515
-66% -$26.3K 0.06% 187
2016
Q2
$42K Sell
780
-66
-8% -$3.25K 0.2% 148
2016
Q1
$42K Buy
+846
New +$39K 0.18% 152

Other funds holding AEE

New York Life Trust's AEE Position: Q1 2017 in Review

New York Life Trust reduced its Ameren (AEE) stake by 91% in Q1 2017, selling an estimated $7.44K and leaving 13 shares worth $1K. The position accounts for 0.05% of the portfolio, ranked #179.

New York Life Trust first reported a position in AEE in Q1 2016 and has held it in 5 quarters since. The position peaked at $42K in Q2 2016. 495 funds tracked by Wall St. Rank hold AEE as of Q1 2017.

  • New York Life Trust held 13 shares of Ameren worth $1K as of Q1 2017.
  • New York Life Trust sold 139 Ameren shares in Q1 2017, an estimated $7.44K.
  • Ameren made up 0.05% of New York Life Trust's portfolio in Q1 2017, its #179 holding.
  • New York Life Trust first reported a position in Ameren in Q1 2016 and has held it in 5 quarters since.
  • New York Life Trust's Ameren position peaked at $42K in Q2 2016.
  • 495 funds tracked by Wall St. Rank held Ameren as of Q1 2017.

Based on New York Life Trust's 13F filing for Q1 2017, filed 12 May 2017.